Nabumetone is a methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs. Among its listed roles, it functions as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a cyclooxygenase 2 inhibitor and a prodrug. It is a methoxynaphthalene and a methyl ketone. It is grouped under the following drug class(es): Cyclooxygenase‑1 (COX‑1) Inhibitors, Cyclooxygenase‑2 (COX‑2) Inhibitors and Non-Steroidal Anti-Inflammatory Drugs (NSAID). Its therapeutic use is listed as analgesics, anti-inflammatories, antipyretics and osteoarthritis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Relafen, 4-(6-methoxynaphthalen-2-yl)butan-2-one and Nabumetona. Its PubChem CID is 4409.
Nabumetone
| CAS No | 42924-53-8 |
|---|---|
| Molecular Formula | C15H16O2 |
| Molecular Weight | 228.29 g/mol |
| Synonyms | 4-(6-methoxynaphthalen-2-yl)butan-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nabumetone is a methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration.
The listed CAS number is 42924-53-8.
The listed molecular formula is C15H16O2.
The listed molecular weight is 228.29 g/mol.
4-(6-methoxynaphthalen-2-yl)butan-2-one.
The source lists Relafen, 4-(6-methoxynaphthalen-2-yl)butan-2-one and Nabumetona.